Praxis Precision Medicines (PRAX) Amortizatization of Intangibles (2021 - 2026)
Praxis Precision Medicines' (PRAX) quarterly Amortizatization of Intangibles came in at $655000.0 in Q1 2026, down 46.7% year-on-year from $1.2 million in Q1 2025, and down 2.38% quarter-over-quarter from $671000.0 in Q4 2025.
Praxis Precision Medicines (PRAX) Amortizatization of Intangibles (2021 - 2026) Analysis & Trends
Praxis Precision Medicines' Amortizatization of Intangibles history runs 6 years deep, the most recent figure standing at $655000.0 for Q1 2026.
- On a quarterly basis, Amortizatization of Intangibles fell 46.7% year-over-year to $655000.0 in Q1 2026; TTM through Mar 2026 was $3.0 million, a 50.97% decrease from a year earlier, with the FY2025 full-year figure at $3.6 million, down 28.3% from the prior year.
- Amortizatization of Intangibles fell to $655000.0 in Q1 2026 per PRAX's latest filing, from $671000.0 in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $2.0 million in Q3 2024 and bottomed at -$375000.0 in Q1 2022.
- The 5-year median for Amortizatization of Intangibles is $655000.0 (2026), against an average of $547133.3.
- Across the five-year window, Amortizatization of Intangibles soared 76650.0% in 2024 and plunged 64.84% in 2025, its largest moves.
- Year by year, Amortizatization of Intangibles stood at -$196000.0 in 2022, then soared by 98.98% to -$2000.0 in 2023, then surged by 69600.0% to $1.4 million in 2024, then plunged by 51.73% to $671000.0 in 2025, then declined by 2.38% to $655000.0 in 2026.
- Per Business Quant, the three latest PRAX Amortizatization of Intangibles figures stand at $655000.0 (Q1 2026), $671000.0 (Q4 2025), and $705000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 3.22 Mn |
| 10 | Praxis Precision Medicines | 9.20 Bn | 8.42 Bn | - | 655,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 655,000.00 |
| Mar 31, 2026 | 655,000.00 |
| Dec 31, 2025 | 671,000.00 |
| Dec 31, 2025 | 671,000.00 |
| Sep 30, 2025 | 705,000.00 |
| Sep 30, 2025 | 705,000.00 |
| Jun 30, 2025 | 987,000.00 |
| Jun 30, 2025 | 987,000.00 |
| Mar 31, 2025 | 1.23 Mn |
| Mar 31, 2025 | 1.23 Mn |
| Dec 31, 2024 | 1.39 Mn |
| Dec 31, 2024 | 1.39 Mn |
| Sep 30, 2024 | 2.01 Mn |
| Sep 30, 2024 | 2.01 Mn |
| Jun 30, 2024 | 1.53 Mn |
| Jun 30, 2024 | 1.53 Mn |
| Mar 31, 2024 | 84,000.00 |
| Mar 31, 2024 | 84,000.00 |
| Jun 30, 2023 | -2,000.00 |
| Jun 30, 2023 | -2,000.00 |